Dog, Inc.. How a Collection of Visionaries, Rebels, Eccentrics, and Their Pets Launched the Commercial Dog Cloning Industry
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub protégé est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
- Non compatible avec un achat hors France métropolitaine
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
C'est si simple ! Lisez votre ebook avec l'app Vivlio sur votre tablette, mobile ou ordinateur :
- Nombre de pages320
- FormatePub
- ISBN978-1-101-49489-9
- EAN9781101494899
- Date de parution30/12/2010
- Protection num.Adobe DRM
- Taille449 Ko
- Infos supplémentairesepub
- ÉditeurAvery
Résumé
What Stiff did for the dead and Fast Food Nation did for the burger, Dog, Inc. does for the stranger-than-fiction world of commercial dog cloning. It all began with a pit bull named Booger. Former Miss Wyoming Bernann McKinney was so distraught over the death of her dog, whom she regarded as her guardian and savior, that she paid $50, 000 to RNL Bio for the chance to bring her beloved companion back to life.
The result were five new Boogers-the first successful commercial cloning of a canine- delivered in 2008, along with a slew of compelling questions about the boundaries of science, commerce, and ethics. Blending shocking investigative reporting with colorful anecdotes, Pulitzer Prize-winning John Woestendiek takes readers behind the scenes of this emerging industry. But Dog, Inc. isn't just a book about pets.
Nor is it just a book about science. Rather it's a fascinating look at how our emotional needs are bending the reaches of science and technology, as well as a study of this uncharted territory. With our pet obsession climbing to new heights and our scientific abilities even more so, this combination raises a serious concern: Are we crossing the boundary of controlling science in the name of science, in the name of love, in the name of merchandising-or a blend of all three?
The result were five new Boogers-the first successful commercial cloning of a canine- delivered in 2008, along with a slew of compelling questions about the boundaries of science, commerce, and ethics. Blending shocking investigative reporting with colorful anecdotes, Pulitzer Prize-winning John Woestendiek takes readers behind the scenes of this emerging industry. But Dog, Inc. isn't just a book about pets.
Nor is it just a book about science. Rather it's a fascinating look at how our emotional needs are bending the reaches of science and technology, as well as a study of this uncharted territory. With our pet obsession climbing to new heights and our scientific abilities even more so, this combination raises a serious concern: Are we crossing the boundary of controlling science in the name of science, in the name of love, in the name of merchandising-or a blend of all three?
What Stiff did for the dead and Fast Food Nation did for the burger, Dog, Inc. does for the stranger-than-fiction world of commercial dog cloning. It all began with a pit bull named Booger. Former Miss Wyoming Bernann McKinney was so distraught over the death of her dog, whom she regarded as her guardian and savior, that she paid $50, 000 to RNL Bio for the chance to bring her beloved companion back to life.
The result were five new Boogers-the first successful commercial cloning of a canine- delivered in 2008, along with a slew of compelling questions about the boundaries of science, commerce, and ethics. Blending shocking investigative reporting with colorful anecdotes, Pulitzer Prize-winning John Woestendiek takes readers behind the scenes of this emerging industry. But Dog, Inc. isn't just a book about pets.
Nor is it just a book about science. Rather it's a fascinating look at how our emotional needs are bending the reaches of science and technology, as well as a study of this uncharted territory. With our pet obsession climbing to new heights and our scientific abilities even more so, this combination raises a serious concern: Are we crossing the boundary of controlling science in the name of science, in the name of love, in the name of merchandising-or a blend of all three?
The result were five new Boogers-the first successful commercial cloning of a canine- delivered in 2008, along with a slew of compelling questions about the boundaries of science, commerce, and ethics. Blending shocking investigative reporting with colorful anecdotes, Pulitzer Prize-winning John Woestendiek takes readers behind the scenes of this emerging industry. But Dog, Inc. isn't just a book about pets.
Nor is it just a book about science. Rather it's a fascinating look at how our emotional needs are bending the reaches of science and technology, as well as a study of this uncharted territory. With our pet obsession climbing to new heights and our scientific abilities even more so, this combination raises a serious concern: Are we crossing the boundary of controlling science in the name of science, in the name of love, in the name of merchandising-or a blend of all three?